Research And Development
Health
Therapy

Kitov Pharmaceuticals

$0.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.035 (-3.66%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell KTOV and other stocks, options, ETFs, and crypto commission-free!

About KTOV

Kitov Pharma Ltd. American Depositary Shares, also called Kitov Pharmaceuticals, is a development stage pharmaceutical company, which engages in drug development. Read More It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.

Employees
10
Headquarters
Tel Aviv, Tel Aviv
Founded
2010
Market Cap
15.05M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
148.05K
High Today
$0.93
Low Today
$0.91
Open Price
$0.9102
Volume
43.22K
52 Week High
$2.92
52 Week Low
$0.56

Collections

Research And Development
Health
Therapy
Medical
Pharmaceutical
Technology
2015 IPO
US
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.